Radiopharmaceuticals in Nuclear Medicine Market Report

Japan Radiopharmaceuticals in Nuclear Medicine Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 17, 2019
  • PAGES：147
  • REPORT CODE：GMM291626
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Radiopharmaceuticals in Nuclear Medicine market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Radiopharmaceuticals in Nuclear Medicine market. Detailed analysis of key players, along with key growth strategies adopted by Radiopharmaceuticals in Nuclear Medicine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Medtronic, Inc.

    • Cardinal Health, Inc.

    • General Electric Co. (healthcare division)

    • Jubilant Life science

    • Isotec, Inc (Sigma-Aldrich)

    • Lantheus Medical Imaging

    • Siemens AG

    • Cardinal Health

    • Institute of Atomic Energy Polatom Radioisotope Centre.

    • Curium Pharma

    • Novartis International AG (Advanced accelerator)

    • Mallinckrodt plc

    • Fujifilm Holding Corporation

    • Bayer AG


    By Type:

    • Diagnostic

    • Therapeutic


    By End-User:

    • Oncology

    • Cardiology

    • Neurology

    • Thyroid

    • Others


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Radiopharmaceuticals in Nuclear Medicine Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Diagnostic from 2014 to 2026

      • 1.3.2 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Therapeutic from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.2 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Cardiology from 2014 to 2026

      • 1.4.3 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Neurology from 2014 to 2026

      • 1.4.4 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Thyroid from 2014 to 2026

      • 1.4.5 Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Radiopharmaceuticals in Nuclear Medicine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Radiopharmaceuticals in Nuclear Medicine by Major Types

      • 3.4.1 Market Size and Growth Rate of Diagnostic

      • 3.4.2 Market Size and Growth Rate of Therapeutic

    4 Segmentation of Radiopharmaceuticals in Nuclear Medicine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Radiopharmaceuticals in Nuclear Medicine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Radiopharmaceuticals in Nuclear Medicine in Oncology

      • 4.4.2 Market Size and Growth Rate of Radiopharmaceuticals in Nuclear Medicine in Cardiology

      • 4.4.3 Market Size and Growth Rate of Radiopharmaceuticals in Nuclear Medicine in Neurology

      • 4.4.4 Market Size and Growth Rate of Radiopharmaceuticals in Nuclear Medicine in Thyroid

      • 4.4.5 Market Size and Growth Rate of Radiopharmaceuticals in Nuclear Medicine in Others


    5 Market Analysis by Regions

    • 5.1 Japan Radiopharmaceuticals in Nuclear Medicine Production Analysis by Regions

    • 5.2 Japan Radiopharmaceuticals in Nuclear Medicine Consumption Analysis by Regions


    6 Hokkaido Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 6.1 Hokkaido Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 6.2 Hokkaido Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    7 Tohoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 7.1 Tohoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 7.2 Tohoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    8 Kanto Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 8.1 Kanto Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 8.2 Kanto Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    9 Chubu Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 9.1 Chubu Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 9.2 Chubu Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    10 Kinki Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 10.1 Kinki Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 10.2 Kinki Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    11 Chugoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 11.1 Chugoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 11.2 Chugoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    12 Shikoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 12.1 Shikoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 12.2 Shikoku Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    13 Kyushu Radiopharmaceuticals in Nuclear Medicine Landscape Analysis

    • 13.1 Kyushu Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major Types

    • 13.2 Kyushu Radiopharmaceuticals in Nuclear Medicine Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Medtronic, Inc.

      • 14.1.1 Medtronic, Inc. Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Cardinal Health, Inc.

      • 14.2.1 Cardinal Health, Inc. Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 General Electric Co. (healthcare division)

      • 14.3.1 General Electric Co. (healthcare division) Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Jubilant Life science

      • 14.4.1 Jubilant Life science Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Isotec, Inc (Sigma-Aldrich)

      • 14.5.1 Isotec, Inc (Sigma-Aldrich) Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Lantheus Medical Imaging

      • 14.6.1 Lantheus Medical Imaging Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Siemens AG

      • 14.7.1 Siemens AG Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Cardinal Health

      • 14.8.1 Cardinal Health Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Institute of Atomic Energy Polatom Radioisotope Centre.

      • 14.9.1 Institute of Atomic Energy Polatom Radioisotope Centre. Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Curium Pharma

      • 14.10.1 Curium Pharma Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Novartis International AG (Advanced accelerator)

      • 14.11.1 Novartis International AG (Advanced accelerator) Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Mallinckrodt plc

      • 14.12.1 Mallinckrodt plc Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 Fujifilm Holding Corporation

      • 14.13.1 Fujifilm Holding Corporation Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

    • 14.14 Bayer AG

      • 14.14.1 Bayer AG Company Profile and Recent Development

      • 14.14.2 Market Performance

      • 14.14.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 138 Figures and 125 Tables)

     

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Diagnostic from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Therapeutic from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Neurology from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Thyroid from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Radiopharmaceuticals in Nuclear Medicine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Radiopharmaceuticals in Nuclear Medicine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Radiopharmaceuticals in Nuclear Medicine by Different Types from 2014 to 2026

    • Table Consumption Share of Radiopharmaceuticals in Nuclear Medicine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Diagnostic

    • Figure Market Size and Growth Rate of Therapeutic

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Radiopharmaceuticals in Nuclear Medicine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Radiopharmaceuticals in Nuclear Medicine by Different End-Users from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Neurology from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Thyroid from 2014 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Radiopharmaceuticals in Nuclear Medicine Production by Regions

    • Table Japan Radiopharmaceuticals in Nuclear Medicine Production Share by Regions

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Production Share by Regions in 2014

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Production Share by Regions in 2018

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Production Share by Regions in 2026

    • Table Japan Radiopharmaceuticals in Nuclear Medicine Consumption by Regions

    • Table Japan Radiopharmaceuticals in Nuclear Medicine Consumption Share by Regions

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Consumption Share by Regions in 2014

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Consumption Share by Regions in 2018

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Consumption Share by Regions in 2026

    • Table Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Hokkaido Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Tohoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Kanto Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Kanto Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Kanto Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Chubu Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Chubu Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Chubu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Kinki Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Kinki Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Kinki Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Chugoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Shikoku Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2014

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2018

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by Types in 2026

    • Table Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2014

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2018

    • Figure Kyushu Radiopharmaceuticals in Nuclear Medicine Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Medtronic, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medtronic, Inc.

    • Figure Sales and Growth Rate Analysis of Medtronic, Inc.

    • Figure Revenue and Market Share Analysis of Medtronic, Inc.

    • Table Product and Service Introduction of Medtronic, Inc.

    • Table Company Profile and Development Status of Cardinal Health, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cardinal Health, Inc.

    • Figure Sales and Growth Rate Analysis of Cardinal Health, Inc.

    • Figure Revenue and Market Share Analysis of Cardinal Health, Inc.

    • Table Product and Service Introduction of Cardinal Health, Inc.

    • Table Company Profile and Development Status of General Electric Co. (healthcare division)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of General Electric Co. (healthcare division)

    • Figure Sales and Growth Rate Analysis of General Electric Co. (healthcare division)

    • Figure Revenue and Market Share Analysis of General Electric Co. (healthcare division)

    • Table Product and Service Introduction of General Electric Co. (healthcare division)

    • Table Company Profile and Development Status of Jubilant Life science

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Life science

    • Figure Sales and Growth Rate Analysis of Jubilant Life science

    • Figure Revenue and Market Share Analysis of Jubilant Life science

    • Table Product and Service Introduction of Jubilant Life science

    • Table Company Profile and Development Status of Isotec, Inc (Sigma-Aldrich)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Isotec, Inc (Sigma-Aldrich)

    • Figure Sales and Growth Rate Analysis of Isotec, Inc (Sigma-Aldrich)

    • Figure Revenue and Market Share Analysis of Isotec, Inc (Sigma-Aldrich)

    • Table Product and Service Introduction of Isotec, Inc (Sigma-Aldrich)

    • Table Company Profile and Development Status of Lantheus Medical Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus Medical Imaging

    • Figure Sales and Growth Rate Analysis of Lantheus Medical Imaging

    • Figure Revenue and Market Share Analysis of Lantheus Medical Imaging

    • Table Product and Service Introduction of Lantheus Medical Imaging

    • Table Company Profile and Development Status of Siemens AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens AG

    • Figure Sales and Growth Rate Analysis of Siemens AG

    • Figure Revenue and Market Share Analysis of Siemens AG

    • Table Product and Service Introduction of Siemens AG

    • Table Company Profile and Development Status of Cardinal Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cardinal Health

    • Figure Sales and Growth Rate Analysis of Cardinal Health

    • Figure Revenue and Market Share Analysis of Cardinal Health

    • Table Product and Service Introduction of Cardinal Health

    • Table Company Profile and Development Status of Institute of Atomic Energy Polatom Radioisotope Centre.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Institute of Atomic Energy Polatom Radioisotope Centre.

    • Figure Sales and Growth Rate Analysis of Institute of Atomic Energy Polatom Radioisotope Centre.

    • Figure Revenue and Market Share Analysis of Institute of Atomic Energy Polatom Radioisotope Centre.

    • Table Product and Service Introduction of Institute of Atomic Energy Polatom Radioisotope Centre.

    • Table Company Profile and Development Status of Curium Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Curium Pharma

    • Figure Sales and Growth Rate Analysis of Curium Pharma

    • Figure Revenue and Market Share Analysis of Curium Pharma

    • Table Product and Service Introduction of Curium Pharma

    • Table Company Profile and Development Status of Novartis International AG (Advanced accelerator)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis International AG (Advanced accelerator)

    • Figure Sales and Growth Rate Analysis of Novartis International AG (Advanced accelerator)

    • Figure Revenue and Market Share Analysis of Novartis International AG (Advanced accelerator)

    • Table Product and Service Introduction of Novartis International AG (Advanced accelerator)

    • Table Company Profile and Development Status of Mallinckrodt plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt plc

    • Figure Sales and Growth Rate Analysis of Mallinckrodt plc

    • Figure Revenue and Market Share Analysis of Mallinckrodt plc

    • Table Product and Service Introduction of Mallinckrodt plc

    • Table Company Profile and Development Status of Fujifilm Holding Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fujifilm Holding Corporation

    • Figure Sales and Growth Rate Analysis of Fujifilm Holding Corporation

    • Figure Revenue and Market Share Analysis of Fujifilm Holding Corporation

    • Table Product and Service Introduction of Fujifilm Holding Corporation

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US